Skip to main content

Part of the book series: Fortschritte der praktischen Dermatologie und Venerologie ((DERMATOLOGIE,volume 19))

  • 228 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Antoni C, Kavanaugh A, Kirkham B, et al. (2003) The one year results of the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum 48: 265–266

    Google Scholar 

  2. Antoni E, Kavanaugh A, Gladman D et al. (2004) The infliximab multinational psoriatic arthritis controlled trial (IMPACT): results of radiographic analyses after 1 year. Arthritis Rheum; 50(suppl): ACR, abstr. 1135

    Google Scholar 

  3. Bruce IN, Gladman DD (1998) Psoriatic arthritis. Recognition and management. Bio Drugs 9: 271–278

    CAS  Google Scholar 

  4. Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB (2000) Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 43: 1244–1256

    Article  CAS  PubMed  Google Scholar 

  5. Espinoza LR, Zakraoui L, Espinoza CG, Gutierrez F, Jara LJ, Silveira LH, Cuellar ML, Martinez-Osuna P (1992) Psoriatic arthritis: clincal responses and side effects to methotrexate therapy. J Rheumatol 12: 872–877

    Google Scholar 

  6. Gladman DD, Farewell VT (1995) The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Arthritis Rheum 38: 845–850

    Article  CAS  PubMed  Google Scholar 

  7. Gladman DD, Farewell VT, Nadeau C (1995) Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 22: 675–679

    CAS  PubMed  Google Scholar 

  8. Gladman DD, Farewell VT, Wong K, Husted J (1998) Mortality studies in psoriatic arthritis. Results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41: 1103–1110

    Article  CAS  PubMed  Google Scholar 

  9. Harrison BJ, Silman AJ, Barrett EM, Scott DG, Symmons DP (1997) Presence of psoriasis does not influence the presentation or short term outcome of patients with early inflammatory polyarthritis. J Rheumatol 24: 1744–1749

    CAS  PubMed  Google Scholar 

  10. Leczinsky CG (1948) The incidence of arthropathy in a ten-year series of psoriasis cases. Acta Dermato venerol 28: 483–487

    CAS  Google Scholar 

  11. Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E (1999) Clinical, radiographic and HLA associations as markers of different patterns of psoriatic arthritis. Br J Rheumatol 38: 332–337

    Article  CAS  Google Scholar 

  12. Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etancercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356: 385–390

    Article  CAS  PubMed  Google Scholar 

  13. Menter MA, Gordon KB, Leonardi C et al. (2004) Adalimumab efficacy and safety results in patients with moderate to severe chronic plaque psoriasis with and without PsA. Arthritis Rheum 50(suppl): ACR 2004, abstr. 1622 [Finde ich nicht veröffentlicht]

    Google Scholar 

  14. Moll JMH, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3: 55–78

    Article  CAS  PubMed  Google Scholar 

  15. Scarpa R, Oriente P, Pucino A, Torella M, Vignone L, Riccio A, Biondi Oriente C (1984) Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23: 246–520

    Article  CAS  PubMed  Google Scholar 

  16. Veale D, Rodgers S, Fitzgerald D (1994) Classification of clinical subsets in psoriatic arthritis. Br J Rheumatol 33: 133–138

    Article  CAS  PubMed  Google Scholar 

  17. Wang Q, Vasey FB, Mahfood JP, Valeriano J, Kanik KS, Anderson BE, Bridgeford PH (1999) V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum 42: 2055–2059

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Gerd Plewig (Prof. Dr. med. Dr. h.c.)Peter Kaudewitz (Prof. Dr. med.)Christian A. Sander (Priv.-Doz. Dr. med.)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schewe, S. (2005). Psoriasis-Arthritis. In: Plewig, G., Kaudewitz, P., Sander, C.A. (eds) Fortschritte der praktischen Dermatologie und Venerologie. Fortschritte der praktischen Dermatologie und Venerologie, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28691-8_35

Download citation

  • DOI: https://doi.org/10.1007/3-540-28691-8_35

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21055-9

  • Online ISBN: 978-3-540-28691-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics